Small-Molecule Inhibitors in Glioblastoma: Key Pathways and Resistance Mechanisms
Glioblastoma, the most common and aggressive form of primary adult brain tumor, is a
devastating disease with a dismal two-year survival. Attempts to improve patient survival …
devastating disease with a dismal two-year survival. Attempts to improve patient survival …
[引用][C] TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR: AN IMPORTANT STRATEGY IN ONCOLOGY
MG KHARATMOL, DM JAGDALE